Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Criscitiello

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Breast Care (Basel, Switzerland)|August 2, 2013
Tumor-associated antigens in breast cancerCarmen Criscitiello
Genes|September 23, 2022
Breast Cancer Genetics: Diagnostics and TreatmentCarmen Criscitiello, Chiara Corti
European Journal of Cancer (Oxford, England : 1990)|January 25, 2020
Tumour infiltrating lymphocytes and correlation with response to intensified platinum-based chemotherapy in BRCA-like tumoursCarmen Criscitiello, Giuseppe Curigliano
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
Treatment in real-life patients with HER2-positive metastatic breast cancer: What we learn from the KAMILLA trial?Carmen Criscitiello, Giuseppe Curigliano
Future Oncology (London, England)|February 19, 2013
HER2 signaling pathway and trastuzumab cardiotoxicityCarmen Criscitiello, Giuseppe Curigliano
Progress in Tumor Research|April 15, 2014
Successes and limitations of targeted cancer therapy in breast cancerGiuseppe Curigliano, Carmen Criscitiello
Current Opinion in Oncology|October 1, 2013
Immunotherapeutics for breast cancerCarmen Criscitiello, Giuseppe Curigliano
Progress in Tumor Research|September 18, 2015
Immunotherapy of Breast CancerCarmen Criscitiello, Giuseppe Curigliano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2017
Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast CancerGiuseppe Curigliano, Carmen Criscitiello
Current Opinion in Oncology|October 9, 2019
Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancerCarmen Criscitiello, Giulia Viale, Giuseppe Curigliano
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Breast Care (Basel, Switzerland)|August 2, 2013
Tumor-associated antigens in breast cancerCarmen Criscitiello
Genes|September 23, 2022
Breast Cancer Genetics: Diagnostics and TreatmentCarmen Criscitiello, Chiara Corti
European Journal of Cancer (Oxford, England : 1990)|January 25, 2020
Tumour infiltrating lymphocytes and correlation with response to intensified platinum-based chemotherapy in BRCA-like tumoursCarmen Criscitiello, Giuseppe Curigliano
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
Treatment in real-life patients with HER2-positive metastatic breast cancer: What we learn from the KAMILLA trial?Carmen Criscitiello, Giuseppe Curigliano
Future Oncology (London, England)|February 19, 2013
HER2 signaling pathway and trastuzumab cardiotoxicityCarmen Criscitiello, Giuseppe Curigliano
Progress in Tumor Research|April 15, 2014
Successes and limitations of targeted cancer therapy in breast cancerGiuseppe Curigliano, Carmen Criscitiello
Current Opinion in Oncology|October 1, 2013
Immunotherapeutics for breast cancerCarmen Criscitiello, Giuseppe Curigliano
Progress in Tumor Research|September 18, 2015
Immunotherapy of Breast CancerCarmen Criscitiello, Giuseppe Curigliano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2017
Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast CancerGiuseppe Curigliano, Carmen Criscitiello
Current Opinion in Oncology|October 9, 2019
Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancerCarmen Criscitiello, Giulia Viale, Giuseppe Curigliano
Pageof 22